Literature DB >> 22871498

Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease.

Naim Alkhouri1, Rita De Vito, Anna Alisi, Lisa Yerian, Rocio Lopez, Ariel E Feldstein, Valerio Nobili.   

Abstract

BACKGROUND & AIMS: Pediatric non-alcoholic fatty liver disease (NAFLD) may present with a distinct histopathological pattern characterized by the presence of predominant portal-based injury and portal inflammation (PI). We aimed at developing a new grading score for pediatric NAFLD to be used in clinical trials that takes into account the presence of PI and the weight of histological features.
METHODS: Our training set consisted of 203 children with biopsy-proven NAFLD. The diagnosis of non-alcoholic steatohepatitis (NASH) was based on Brunt's criteria. Histological features were scored: steatosis (0-3), lobular inflammation (0-3), ballooning (0-2), and PI (0-2). Logistic regression analysis was performed to apply weight to each feature. The new score was called the Pediatric NAFLD Histological Score or PNHS. The validation set consisted of 100 children with NAFLD.
RESULTS: The mean age of the initial cohort was 12.4 ± 3.4 years and significant fibrosis (fibrosis stage ≥ 2) was present in 26 patients (12.8%). NASH was diagnosed in 135 patients with a mean NAS of 4.5 ± 1.4. The mean PNHS in the NASH group was 89 ± 20.5 compared to 21.9 ± 24.5 in the "not NASH" group, p<0.001. PNHS correlated with the presence of NASH according to the pathologist's diagnosis, better than the NAFLD activity score (NAS), p=0.011. The area under the ROC curve (AUC) for the diagnosis of NASH was 0.96 for PNHS. Similar findings were observed in the validation set with an AUC of 0.94.
CONCLUSIONS: PNHS may be used for histological grading of pediatric NAFLD with excellent correlation with the presence of NASH.
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22871498     DOI: 10.1016/j.jhep.2012.07.027

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  27 in total

Review 1.  The role of the gut microbiota in NAFLD.

Authors:  Christopher Leung; Leni Rivera; John B Furness; Peter W Angus
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-08       Impact factor: 46.802

Review 2.  Role of diet on non-alcoholic fatty liver disease: An updated narrative review.

Authors:  Dimitrios Papandreou; Eleni Andreou
Journal:  World J Hepatol       Date:  2015-03-27

Review 3.  Clinical features of pediatric nonalcoholic fatty liver disease: a need for increased awareness and a consensus for screening.

Authors:  Jeremy P Middleton; R Constance Wiener; Barrett H Barnes; Matthew J Gurka; Mark D DeBoer
Journal:  Clin Pediatr (Phila)       Date:  2014-01-28       Impact factor: 1.168

4.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

Authors: 
Journal:  Diabetologia       Date:  2016-06       Impact factor: 10.122

5.  Macrophages and fibrosis in adipose tissue are linked to liver damage and metabolic risk in obese children.

Authors:  Ryan W Walker; Hooman Allayee; Alessandro Inserra; Rodolfo Fruhwirth; Anna Alisi; Rita Devito; Magalie E Carey; Frank Sinatra; Michael I Goran; Valerio Nobili
Journal:  Obesity (Silver Spring)       Date:  2014-03-08       Impact factor: 5.002

Review 6.  Pediatric Non-alcoholic Fatty Liver Disease.

Authors:  Vikas Uppal; Sana Mansoor; Katryn N Furuya
Journal:  Curr Gastroenterol Rep       Date:  2016-05

7.  The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.

Authors:  Sana Mansoor; Lisa Yerian; Rohit Kohli; Stavra Xanthakos; Paul Angulo; Simon Ling; Rocio Lopez; Carter-Kent Christine; Ariel E Feldstein; Naim Alkhouri
Journal:  Dig Dis Sci       Date:  2014-12-25       Impact factor: 3.199

8.  Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients.

Authors:  Mazen Noureddin; Katherine P Yates; Ivana A Vaughn; Brent A Neuschwander-Tetri; Arun J Sanyal; Arthur McCullough; Raphael Merriman; Bilal Hameed; Edward Doo; David E Kleiner; Cynthia Behling; Rohit Loomba
Journal:  Hepatology       Date:  2013-10-02       Impact factor: 17.425

Review 9.  Role of liver biopsy in nonalcoholic fatty liver disease.

Authors:  I L Ke Nalbantoglu; Elizabeth M Brunt
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 10.  Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease.

Authors:  Peter R Baker; Jacob E Friedman
Journal:  J Clin Invest       Date:  2018-08-31       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.